touchIME® would like to include your questions in an upcoming panel discussion. Please submit your question to the faculty below and we will consider these as part of the activity.
Internationally renowned head and neck cancer expert Prof. Kevin Harrington from The Royal Marsden NHS Foundation, London, UK, will chair a panel discussion on the role of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
To ensure the discussion is relevant to your clinical practice, we’d love to hear your questions for the panel on the following topics:
- Interpreting clinical trial data for immune checkpoint inhibitors in recurrent/metastatic HNSCC for application to clinical practice
- Factors that may guide the use of immune checkpoint inhibitors, e.g. biomarkers
- Monitoring for and managing immune-related adverse events